Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02444832

Acronym

MACAARET

Enrollment

300

Registered

2015-05-15

Start date

2015-05-31

Completion date

2017-12-31

Last updated

2015-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm, Ruptured, Anterior Communicating Artery Aneurysm, Cerebral Aneurysm, Intracranial Aneurysm

Brief summary

Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy. The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms. Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported. The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling. The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patient with Anterior Communicating Artery Aneurysm treated with endovascular coiling.

Exclusion criteria

* Patients without imaging follow up of at least 12 months after endovascular treatment.

Design outcomes

Primary

Measure	Time frame
Effective Aneurysm Coiling (no residual cerebral aneurysm)	1 year

Secondary

Measure	Time frame	Description
All Cause Mortality	1 year	—
Neurological Outcome (classified with the Glasgow Outcome Scale, Rankin Scale)	1 year	All patients will be classified with the Glasgow Outcome Scale, Rankin Scale.
Procedural device-related serious adverse events	1 year	—

Countries

Spain

Contacts

Primary ContactFederico Zarco, MD

fzarco@clinic.ub.es932275400

Outcome results